These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 2476594

  • 1. CGP 38 560: orally active, low-molecular-weight renin inhibitor with high potency and specificity.
    Wood JM, Criscione L, de Gasparo M, Bühlmayer P, Rüeger H, Stanton JL, Jupp RA, Kay J.
    J Cardiovasc Pharmacol; 1989 Aug; 14(2):221-6. PubMed ID: 2476594
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of a potent inhibitor of subprimate and primate renins.
    Wood JM, Mah SC, Baum HP, de Gasparo M, Cumin F, Rüeger H, Nussberger J.
    J Pharmacol Exp Ther; 1990 May; 253(2):513-7. PubMed ID: 2110974
    [Abstract] [Full Text] [Related]

  • 3. [In vitro and in vivo inhibition of renin by a thiazolylalanyl cyclostatine derivative].
    Muneta S.
    Nihon Jinzo Gakkai Shi; 1989 Aug; 31(8):865. PubMed ID: 2512401
    [Abstract] [Full Text] [Related]

  • 4. Effects of a specific and long-acting renin inhibitor in the marmoset.
    Wood JM, Gulati N, Forgiarini P, Fuhrer W, Hofbauer KG.
    Hypertension; 1985 Aug; 7(5):797-803. PubMed ID: 3928488
    [Abstract] [Full Text] [Related]

  • 5. Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans.
    Fisher ND, Jan Danser AH, Nussberger J, Dole WP, Hollenberg NK.
    Circulation; 2008 Jun 24; 117(25):3199-205. PubMed ID: 18559696
    [Abstract] [Full Text] [Related]

  • 6. Effects of the renin inhibitor N-[N-(3-(4-amino-1-piperidinyl-carbonyl)-2(R)-benzylpropionyl)-L- histid inyl] -(2S,3R,4S)-1-cyclohexyl-3,4-dihydroxy-6(2-pyridyl)-hexane-2-amide acetate in anesthetized rhesus monkeys.
    Linz W, Heitsch H, Henning R, Jung W, Kleemann HW, Nickel WU, Ruppert D, Urbach H, Wagner A, Schölkens BA.
    Arzneimittelforschung; 1994 Jul 24; 44(7):815-20. PubMed ID: 7945514
    [Abstract] [Full Text] [Related]

  • 7. Acute hypotensive responses to peptide inhibitors of renin in conscious monkeys: an effect on blood pressure independent of plasma renin inhibition.
    Schaffer LW, Schorn TW, Winquist RJ, Strouse JF, Payne L, Chakravarty PK, de Laszlo SE, tenBroeke J, Veber DF, Greenlee WJ.
    J Hypertens; 1990 Mar 24; 8(3):251-9. PubMed ID: 2159506
    [Abstract] [Full Text] [Related]

  • 8. The human renin infused rat: use as an in vivo model for the biological evaluation of human renin inhibitors.
    Bolger G, Vigeant JC, Liard F, Simoneau B, Thibeault D, Pilote L, Lamarre D, Jung G, Anderson P, Jaramillo J.
    Can J Physiol Pharmacol; 1999 Nov 24; 77(11):886-95. PubMed ID: 10593662
    [Abstract] [Full Text] [Related]

  • 9. Effect of an orally active renin inhibitor Cl-992 on blood pressure in normotensive and hypertensive monkeys.
    Ryan MJ, Hicks GW, Batley BL, Rapundalo ST, Patt WC, Taylor DG, Keiser JA.
    J Pharmacol Exp Ther; 1994 Jan 24; 268(1):372-9. PubMed ID: 8301578
    [Abstract] [Full Text] [Related]

  • 10. Acute and chronic effects of renin inhibitor GR70982 in the conscious marmoset.
    Gardner CJ, Twissell DJ, Charlton PA, Cherry PC.
    Eur J Pharmacol; 1991 Jan 17; 192(3):329-35. PubMed ID: 1905233
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of renin-like activity in marmoset tissues by the renin inhibitor CGP 29 287.
    Wood JM, Baum HP, Carleton J, Dzau VJ.
    J Hypertens Suppl; 1987 Jul 17; 5(2):S67-9. PubMed ID: 3116182
    [Abstract] [Full Text] [Related]

  • 12. An orally active renin inhibitor: cyclohexylnorstatine-containing dipeptide (KRI-1314).
    Miyazaki M, Etoh Y, Iizuka K, Toda N.
    J Hypertens Suppl; 1989 Apr 17; 7(2):S25-7. PubMed ID: 2666609
    [Abstract] [Full Text] [Related]

  • 13. Increased plasma renin during renin inhibition. Studies with a novel immunoassay.
    Hofbauer KG, Wood JM, Gulati N, Heusser C, Ménard J.
    Hypertension; 1985 Apr 17; 7(3 Pt 2):I61-5. PubMed ID: 2987126
    [Abstract] [Full Text] [Related]

  • 14. Sustained reduction in blood pressure during chronic administration of a renin inhibitor to normotensive marmosets.
    Wood JM, Baum HP, Jobber RA, Neisius D.
    J Cardiovasc Pharmacol; 1987 Apr 17; 10 Suppl 7():S96-8. PubMed ID: 2485073
    [Abstract] [Full Text] [Related]

  • 15. Antihypertensive effect of a renin inhibitor in marmosets with a segmental renal infarction.
    Neisius D, Wood JM.
    J Hypertens; 1987 Dec 17; 5(6):721-5. PubMed ID: 2828470
    [Abstract] [Full Text] [Related]

  • 16. Renin vs. angiotensin-converting enzyme inhibition in the rat: consequences for plasma and renal tissue angiotensin.
    Allan DR, Hui KY, Coletti C, Hollenberg NK.
    J Pharmacol Exp Ther; 1997 Nov 17; 283(2):661-5. PubMed ID: 9353383
    [Abstract] [Full Text] [Related]

  • 17. A highly potent and long-acting oral inhibitor of human renin.
    Hiwada K, Kokubu T, Murakami E, Muneta S, Morisawa Y, Yabe Y, Koike H, Iijima Y.
    Hypertension; 1988 Jun 17; 11(6 Pt 2):708-12. PubMed ID: 3134306
    [Abstract] [Full Text] [Related]

  • 18. Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950.
    Anderson IK, Drew GM.
    Br J Pharmacol; 1997 Dec 17; 122(7):1385-94. PubMed ID: 9421286
    [Abstract] [Full Text] [Related]

  • 19. Monoclonal antibodies against human renin. Blood pressure effects in the marmoset.
    Wood JM, Heusser C, Gulati N, Forgiarini P, Hofbauer KG.
    Hypertension; 1986 Jul 17; 8(7):600-5. PubMed ID: 3013776
    [Abstract] [Full Text] [Related]

  • 20. [Hypotensive effect of a human anti-renin monoclonal antibody (4G1D8) in the sodium-depleted alert marmoset].
    Cazaubon C, Carlet C, Richaud JP, Nisato D, Corvol P, Gagnol JP.
    Arch Mal Coeur Vaiss; 1986 Jun 17; 79(6):840-6. PubMed ID: 3099700
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.